Understanding Virginia's Budget
Picture From our friends over at The Commonwealth Institute: Read More
Budget Items to Highlight
As the Executive Director of the Substance Abuse and Addiction Recovery Alliance of Virginia, I am writing to bring attention to the recently proposed Virginia House of Delegates and Senate budgets for the biennium 2025-26, specifically within the Health and Human Services sector. Our organization is dedicated to addressing the complex issues surrounding substance use disorders, addiction, and recovery in the Commonwealth.
After careful review, I would like to highlight key budget items from both the House of Delegates and Senate proposals that are of particular relevance to our mission. The aim is to draw attention to these critical areas and advocate for continued support and funding.
From the Virginia House of Delegates Budget:
1. Naloxone Distribution in Public Schools ($100,000): We appreciate the commitment to ensuring the availability of naloxone in public schools to address opioid-related emergencies. This initiative aligns with our mission to promote safety and awareness.
2. Expand Permanent Supportive Housing ($10,000,000): Adequate housing is essential for individuals in recovery. We commend the allocation of funds to expand Permanent Supportive Housing, as it contributes significantly to the overall well-being of those overcoming addiction.
3. Increase Funding for STEP-VA ($9,000,000): The Substance Use Disorder Treatment Expansion and Enhancement Act (STEP-VA) is crucial in addressing the treatment needs of individuals with substance use disorders. We recommend the proposed funding increase to strengthen the program.
4. Opioid Abatement Authority ($30,438,290): The opioid epidemic remains a significant public health concern. We support the funding for the Opioid Abatement Authority and urge its continued prioritization to address the multifaceted challenges posed by opioid use.
5. Virginia Association of Recovery Residences ($1,000,000): Recognizing the importance of stable housing in the recovery process, we support the allocation of funds to the Virginia Association of Recovery Residences. This investment contributes to creating supportive environments for individuals in recovery.
6. Prescription Drug Affordability Board ($1,296,000): The inclusion of funding for the Prescription Drug Affordability Board reflects a forward-thinking approach to address the economic aspects of substance use disorders. This initiative aligns with our mission, as access to affordable medications is crucial for effective treatment and recovery.
7. Rx Partnership ($100,000): Recognizing the importance of collaborative efforts to enhance access to medications, we appreciate the allocation of funds to the Rx Partnership. This organization plays a vital role in ensuring that individuals receive the pharmaceutical support needed in their recovery journey.
From the Virginia Senate Budget:
1. Peer Mentoring Services Rate Increase ($8,500): Recognizing the importance of peer support in the recovery process, we commend the proposal to increase the rates for Peer Mentoring Services. This investment will enhance the effectiveness of peer support programs.
2. Increase Medicaid Rates for Therapeutic Group Homes ($1,016,000): Ensuring adequate reimbursement for therapeutic group homes is essential for providing quality care. We support the proposed increase in Medicaid rates to support these crucial facilities.
3. Opioid Overdose Reversal Agent Program ($8,000,000): The allocation of funds for the Opioid Overdose Reversal Agent Program is pivotal in addressing the immediate challenges posed by opioid overdoses. We endorse and encourage the continuation of this program.
5. Community Services Board Workforce Development ($7,500,000): A robust workforce is essential for effective mental health and substance use disorder services. We commend the Senate's focus on workforce development within Community Services Boards to ensure quality care and support.
6. Prescription Drug Affordability Board (SB 274) ($1,048,950): We commend the Senate for its commitment to the Prescription Drug Affordability Board, as outlined in SB 274. This initiative addresses the pressing issue of drug affordability, directly impacting individuals undergoing substance use disorder treatment.
7. Rx Partnership ($50,000): The proposed funding for the Rx Partnership in the Senate budget further emphasizes the importance of supporting organizations that facilitate the distribution of necessary medications, contributing to the overall effectiveness of substance use disorder treatment.
It is our firm belief that continued investment in these areas will significantly contribute to the overall well-being of individuals struggling with substance use disorders, as well as aid in the prevention and treatment efforts in the Commonwealth.
Sincerely,
Victor McKenzie
Executive Director